C07D 207/14
Nitrogen atoms not forming part of a nitro radical
C07D207/14 (Nitrogen atoms not forming part of a nitro radical) appears on 665 US grants and 735 published applications in this corpus.
Search patents in C07D- Granted patents
- 665
- Published applications
- 735
- Assignees
- 335
- Inventors
- 2,238
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 5 | 0 |
| 1978 | 3 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 6 | 0 |
| 1982 | 7 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 3 | 0 |
| 1986 | 2 | 0 |
| 1987 | 4 | 0 |
| 1988 | 4 | 0 |
| 1989 | 4 | 0 |
| 1990 | 4 | 0 |
| 1991 | 4 | 0 |
| 1992 | 3 | 0 |
| 1993 | 5 | 0 |
| 1994 | 6 | 0 |
| 1995 | 6 | 0 |
| 1996 | 7 | 0 |
| 1997 | 21 | 0 |
| 1998 | 10 | 0 |
| 1999 | 14 | 0 |
| 2000 | 11 | 0 |
| 2001 | 9 | 1 |
| 2002 | 14 | 20 |
| 2003 | 16 | 30 |
| 2004 | 19 | 43 |
| 2005 | 18 | 47 |
| 2006 | 21 | 39 |
| 2007 | 17 | 45 |
| 2008 | 24 | 35 |
| 2009 | 28 | 46 |
| 2010 | 31 | 38 |
| 2011 | 35 | 30 |
| 2012 | 26 | 27 |
| 2013 | 35 | 25 |
| 2014 | 27 | 26 |
| 2015 | 18 | 32 |
| 2016 | 18 | 19 |
| 2017 | 26 | 29 |
| 2018 | 21 | 25 |
| 2019 | 19 | 16 |
| 2020 | 12 | 33 |
| 2021 | 24 | 20 |
| 2022 | 16 | 23 |
| 2023 | 11 | 22 |
| 2024 | 15 | 22 |
| 2025 | 16 | 26 |
| 2026 | 12 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Inhibitors of spinster homolog 2 (SPNS2) for use in therapy22 Sep 2026US 12,741,944 B2University of Virginia Patent Foundation
- Crystalline form III of melanocortin receptor agonist compound and preparation method therefor11 Aug 2026US 12,703,683 B2LG Chem.Ltd.
- Transcriptional enhanced associate domain (TEAD) transcription factor inhibitors and uses thereof4 Aug 2026US 12,698,259 B2Dana-Farber Cancer Institute, Inc.
- 2-(3-ethynylbenzyl)-substituted heterocycle derivatives and related uses14 Jul 2026US 12,679,804 B2Centessa Pharmaceuticals (UK) Limited
- Oxopyrrolidine FPR2 agonists14 Jul 2026US 12,679,823 B2Bristol-Myers Squibb Company
- Novel compound, and pharmaceutical composition comprising same as active ingredient10 Sep 2026US 2026/0265189 A1Sapiensbio Inc.
- Aromatic compounds for use as protein phosphatase 2a (pp2a) modulators10 Sep 2026US 2026/0265190 A1Rappta Therapeutics Oy
- Deubiquitinase inhibitors and methods of use thereof3 Sep 2026US 2026/0258011 A1
- Compounds and compositions for intracellular delivery of nucleic acid-based therapeutics and methods thereof30 Jul 2026US 2026/0216070 A1NanoTech Pharma Inc.
- Lsd1 modulators23 Jul 2026US 2026/0209214 A1Recursion Pharmaceuticals, Inc.
Most cited
By later US patents
- Urea derivatives and their use as ACAT inhibitors134US 5,621,010 ANisshin Flour Milling Co., Ltd. · 1997
- Inhibitors of microsomal triglyceride transfer protein and method84US 5,827,875 ABristol-Myers Squibb Company · 1998
- Dipeptides which promote release of growth hormone79US 5,936,089 APfizer Inc. · 1999
- Antibacterial agents72US 4,665,079 AWarner-Lambert Company · 1987
- 7-(1-pyrrolidinyl)-3-quinolone- and -naphthyridonecarboxylic acid derivatives as antibacterial agents and feed additives69US 4,990,517 ABayer Aktiengesellschaft · 1991